Metabolic factors and the foveal avascular zone of the retina in diabetes mellitus

Diabetes and Metabolism

Volumn 31, Issue 5, 2005, Pages 465-470

  Conrath, J ^a,b   Giorgi, R ^b   Ridings, B ^a   Raccah, D ^b  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Apolipoprotein A1; Body mass index; Diabetic retinopathy; Foveal avascular zone; Macular ischemia

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE SEVERITY; ENDOCRINOLOGY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; IMAGE ANALYSIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OPHTHALMOLOGY; RETINA ISCHEMIA; SEX DIFFERENCE;

EID: 27844437549     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70217-3     Document Type: Article

References (37)

1. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260:2864-71
2. Moss SE, Klein R, Klein BEK. The 14 year incidence of vision loss in a diabetic population. Ophthalmology 1998;105:998-1003
3. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IV. Diabetic macular edema. Ophthalmology 1984;91:1464-74
4. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-806
5. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-24
6. Conrath J, Giorgi R, Raccah D, Ridings B. Foveal avascular zone in diabetic retinopathy, quantitative vs qualitative assessment. Eye 2005;19:322-6
7. Bligard E, De Venecia G, Wallow I, Bresnick G, Syrjala S. Aging changes of the parafoveolar vasculature: a trypsin digest study. Invest Ophthalmol Vis Sci 1982;22:Suppl 8
8. Bradley A, Applegate RA, Zeffren BS, van Heuven WAJ. Psychophysical measurement of the size and shape of the human foveal avascular zone. Ophthal Physiol Opt 1992;12:18-23
9. Yap M, Gilchrist J, Weatherill J. Psychophysical measurement of the foveal avascular zone. Ophthal Physiol Opt 1987;7:405-10
10. Arend O, Wolf S, Jung F, et al. Retinal microcirculation in patients with diabetes mellitus: Dynamic and morphological analysis of perfoveal capillary network. Br J Ophthalmol 1991;75:514-18
11. Bird AC, Weale RA. On the retinal vasculature of the human fovea. Exp Eye Res 1974;19:409-17
12. Bresnick GH, Condit R, Syrjala S, Palta M, Groo A, Korth K. Abnormalities of the foveal avascular zone in diabetic retinopathy. Arch Ophthalmol 1984;102:1286-93
13. Mansour AM, Schachat A, Bodiford G, Haymond R. Foveal avascular zone in diabetes mellitus. Retina 1993;13:125-8
14. Sander B, Larsen M, Engler C, Lund-Andersen H, Parving HH. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmologica 1994;72:553-9
15. Arend O, Wolf S, Harris A, Reim M. The relationship of macular microcirculation to visual acuity in diabetic patients. Arch Ophthalmol 1995;113:610-4
16. ETDRS research group. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Ophthalmology 1991;98:Suppl, 807-22
17. Doft BH, Kingsley LA, Orchard TJ, Kuller L, Drash A, Becker D. The association between long-term diabetic control and early retinopathy. Ophthalmology 1984;91:763-8
18. Bray GA. Weight homeostasis. Annu Rev Med 1991;42:205-16
19. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32
20. West KM, Erdreich LJ, Stober JA. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 1980;29:501-8
21. Nguyen HT, Luzio SD, Dolben J, et al. Dominant risk factors for retinopathy at clinical diagnosis in patients with type 2 diabetes mellitus. J Diab Comp 1996;10:211-9
22. Arend O, Rüffer M, Remky A. Macular circulation in patients with diabetes mellitus with and without arterial hypertension. Br J Ophthalmol 2000;84:1392-6
23. Laatikainen L, Larinkari J. Capillary free area of the fovea with advancing age. Invest Ophthalmol Vis Sci 1977;16:1154-7
24. Kissebah AH, Kohner EM, Lewis B, Siddiq YK, Lowy C, Fraser TR. Plasma-lipids and glucose/insulin relationship in non-insulin-requiring diabetics with and without retinopathy. Lancet 1975;1:1104-7
25. Mohan R, Mohan v, Susheela L, Ramachandran A, Viswanathan M. Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy. Acta Diabetol Lat 1984;21:85-9
26. Davis MD, Fisher MR, Gangnon RE, et al. for the ETDRS Research Group. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: ETDRS Report #18. Invest Ophthalmol Vis Sci 1998;39:233-52
27. Khosla PK, Sharma K, Tewari HK, Bajaj JS, Vaidya MC. Metabolic factors in the development of retinopathy of juvenile-onset type 1 diabetes mellitus. Indian J Ophthalmol 1994;42:23-5
28. Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Arch Ophthalmol 1996;114:1079-84
29. Klein BEK, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991;98:1261-5
30. Lyons TJ, Jenkins AJ, Zheng D, et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 2004;3:910-8
31. Borhani DW, Rogers DP, Engler JA, Brouillette CG. Crystal structure of truncated human apolipoprotein A-1 suggests a lipid-bound conformation. Proc Natl Acad Sci 1997;94:12291-6
32. Walldius G, Jungner I. Apolipoprotein b and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 2004;255:188-205
33. Miyamoto K, Ogura Y. Pathogenetic potential of leukocytes in diabetic retinopathy. Semin Ophthalmol 1999;14:233-9
34. Volger E. Effect of metabolic control and concomittant diseases upon the rheology of blood in different states of diabetic retinopathy. Horm Metab Res Suppl 1981;11:104-7
35. Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 2001;50:1432-9
36. De La Cruz JP, Gonzalez-Correa JA, Guerrero A, de la Cuesta FS. Pharmacological approach to diabetic retinopathy. Diabetes Metab Res Rev 2004;20:91-113
37. Wasenius A, Stugaard M, Otterstad JE, Froyshov D. Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand J Clin Lab Invest 1990;50:635-42